Comparing Afinitor Disperz vs Everolimus
| Afinitor Disperz Remove Afinitor Disperz from your drug comparison | Everolimus Remove Everolimus from your drug comparison |
|---|
| Afinitor Disperz everolimus Remove Afinitor Disperz from your drug comparison | Everolimus Remove Everolimus from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Subependymal Giant Cell Astrocytoma, Tuberous Sclerosis Complex. Afinitor Disperz may also be used for purposes not listed in this medication guide. |
Prescribed for Neuroendocrine Carcinoma, Breast Cancer, Organ Transplant - Rejection Prophylaxis, Pancreatic Cancer, Renal Angiomyolipoma, Renal Cell Carcinoma, Subependymal Giant Cell Astrocytoma,... View more |
|
|||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||||||||||
|
N/A |
5.8
|
||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
|
Common side effects include: infection, decreased hemoglobin, increased serum glucose, lymphocytopenia, and stomatitis. See the full Afinitor Disperz side effects document. |
Commonly reported side effects include: infection, decreased hemoglobin, increased serum glucose, lymphocytopenia, and stomatitis. See the full everolimus side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Afinitor Disperz prices and generic prices |
View all everolimus prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
|
Yes (this medicine) |
|||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
| Other everolimus brands include: Afinitor, Zortress | Afinitor, Afinitor Disperz, Zortress | ||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
|
35 hours |
35 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
Drug Interactions |
|||||||||||||||||
|
A total of 415 drugs are known to interact with Afinitor Disperz:
|
A total of 415 drugs are known to interact with everolimus:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
|
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
|
N/A |
March 30, 2009 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
|
N/A |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
For Neuroendocrine Carcinoma: Started taking everolimus orally 10mg daily December 5, 2017 for pancreatic neuroendocrine tumor metastatic to the liver in combination with a once every four week injection (30 mg) of Octreotide LAR. Tumors actually shrunk some during the first year; since have remained stable to April 2019. Do have occasional side effects - mouth sores, some weakness and fatigue, loose stool to occasional diarrhea. For the most part I function very normally. Good appetite. My weight is reasonably stable, and I do well in spite of a stage IV cancer diagnosis. For "PNET", pancreatic neuroendocrine tumors, this drug appears to be very effective - at least for me.